Form 4/A GOLDEN ENTERTAINMENT, For: May 26 Filed by: Chien Andy H
http://archive.fast-edgar.com/20240524/AM2ZT22CZ228S2Z2222G22EQ4BFWZZ222B62
Filed on: May 24, 2024
Form 3 AEON Biopharma, Inc. For: May 17 Filed by: Sy Jennifer
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 4/A GOLDEN ENTERTAINMENT, For: May 26 Filed by: Dozier Ann
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 DraftKings Inc. For: May 24 Filed by: Ellingson Alan Wayne
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form SC 13D/A Strategic Education, Filed by: INCLUSIVE CAPITAL PARTNERS, L.P.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
Strategic Education, Inc.
(Name of Issuer)Common Stock, par value $0.01 per share
(Title of Class of Securities)86272C103
(CUSIP Number) Philippe B.... (continue reading...)More SEC Filings
View Older Stories-
Form 4 PROCORE TECHNOLOGIES, For: May 22 Filed by: Davis Steven Scott
-
Form 4 PROCORE TECHNOLOGIES, For: May 22 Filed by: Fu Howard
-
Form 4 PROCORE TECHNOLOGIES, For: May 22 Filed by: Durling Joy Driscoll
-
Form 4 PROCORE TECHNOLOGIES, For: May 22 Filed by: Singer Benjamin C
-
Form 4 PROCORE TECHNOLOGIES, For: May 22 Filed by: Fleming William Fred Jr
-
Form 4 PROCORE TECHNOLOGIES, For: May 22 Filed by: Courtemanche Craig F. Jr.
-
Form 144 Strategic Education, Filed by: INCLUSIVE CAPITAL PARTNERS, L.P.
-
Form 4 Finch Therapeutics Group For: May 20 Filed by: SMISEK JEFFERY A
-
Form 4 Hudson Pacific Propertie For: May 22 Filed by: COLEMAN VICTOR J
-
Form 4/A GOLDEN ENTERTAINMENT, For: May 26 Filed by: LIPPARELLI MARK A
-
Form 4 Werewolf Therapeutics, For: May 24 Filed by: Shah Rajeev M.
-
Form 4 Fabrinet For: May 24 Filed by: LEVINSON FRANK H
-
Form 4 Fabrinet For: May 24 Filed by: Olson Rollance E.
-
Form 4 Werewolf Therapeutics, For: May 24 Filed by: DiRocco Derek
-
Form 4/A GOLDEN ENTERTAINMENT, For: May 26 Filed by: Wright Terrence
-
Form 144 PEABODY ENERGY CORP Filed by: Elliott Investment Management L.P.
-
Form 4 POWER SOLUTIONS INTERNAT For: May 15 Filed by: Xykis Constantine
-
Form 4 Werewolf Therapeutics, For: May 24 Filed by: Morrison Briggs
-
Form 4 Werewolf Therapeutics, For: May 24 Filed by: Atkins Michael B.
-
Form 4 Phathom Pharmaceuticals, For: May 23 Filed by: Topper James N
-
Form 4 Werewolf Therapeutics, For: May 24 Filed by: Chatterjee Meeta
-
Form 4 Phathom Pharmaceuticals, For: May 23 Filed by: Parikh Asit
-
Form 4 Werewolf Therapeutics, For: May 24 Filed by: Sherman Michael A.
-
Form 4 Werewolf Therapeutics, For: May 24 Filed by: EVNIN LUKE
-
Form 4 Phathom Pharmaceuticals, For: May 23 Filed by: COLA MICHAEL F
-
Form 4 Werewolf Therapeutics, For: May 24 Filed by: Lazarus Alon
-
Form 4 Phathom Pharmaceuticals, For: May 23 Filed by: FIELDS HEIDI
-
Form 4 KRATOS DEFENSE & SECURIT For: May 24 Filed by: Boyd Bradley L
-
Form 4 Symbotic Inc. For: May 22 Filed by: Cohen Janet L
-
Form 4 KRATOS DEFENSE & SECURIT For: May 24 Filed by: Hagen Daniel J
-
Form 4 Symbotic Inc. For: May 09 Filed by: Ladensohn David A
-
Form 4 Symbotic Inc. For: May 22 Filed by: Dunn Michael David
-
Form SC 13D/A NextDecade Corp. Filed by: York Capital Management Global Advisors, LLC
-
Form 4 Phathom Pharmaceuticals, For: May 23 Filed by: KARBE FRANK
-
Form 4 NextDecade Corp. For: May 22 Filed by: York Credit Opportunities Investment Master Fund, L.P.
-
Form 4 Astra Space, Inc. For: May 16 Filed by: KEMP CHRIS
-
Form 4 TANDEM DIABETES CARE For: May 22 Filed by: Cha Myoungil
-
Form 4 TANDEM DIABETES CARE For: May 22 Filed by: Howell Peyton R
-
Form 4 TANDEM DIABETES CARE For: May 22 Filed by: TWOMEY CHRISTOPHER J
-
Form 4 TANDEM DIABETES CARE For: May 22 Filed by: McGroddy-Goetz Kathleen
-
Form 4 TANDEM DIABETES CARE For: May 22 Filed by: Malagueira Joao Paulo Falcao
-
Form 4 TANDEM DIABETES CARE For: May 22 Filed by: Sodhi Rajwant
-
Form 4 TANDEM DIABETES CARE For: May 22 Filed by: ROBERTSON REBECCA B
-
Form 4 TANDEM DIABETES CARE For: May 22 Filed by: Allen Dick
-
Form 4 TANDEM DIABETES CARE For: May 23 Filed by: BLICKENSTAFF KIM D
-
Form 4 Phathom Pharmaceuticals, For: May 23 Filed by: Stenhouse Mark
-
Form 4 KRATOS DEFENSE & SECURIT For: May 24 Filed by: Fendley Steven S.
-
Form 4 Phathom Pharmaceuticals, For: May 23 Filed by: Socks David A
-
Form 4 Nuvera Communications, For: May 24 Filed by: MEYER PERRY
-
Form 4 Rubicon Technologies, For: May 23 Filed by: Schubert Kevin Michael
